![Biology / Gynaecological cancer / HPV vaccine / Cervarix / Human papillomavirus / Cervical cancer / AS04 / Immunogenicity / Vaccination / Papillomavirus / Medicine / Vaccines Biology / Gynaecological cancer / HPV vaccine / Cervarix / Human papillomavirus / Cervical cancer / AS04 / Immunogenicity / Vaccination / Papillomavirus / Medicine / Vaccines](https://www.pdfsearch.io/img/613e463f9e8ce45523a4489f535310ee.jpg)
| Open Document File Size: 86,78 KBShare Result on Facebook
Company GlaxoSmithKline Biologicals / Glaxosmithkline plc / / Country Germany / Canada / / Event FDA Phase / / IndustryTerm prevention of the following diseases / / MedicalCondition cervical intraepithelial neoplasia / diseases / CIN / HPV / cervical cancer / adenocarcinoma / / MedicalTreatment vaccination / / Organization FDA / sBLA Review Committee / REVIEW COMMITTEE / / Person Estelle Russek-Cohen / A. Dale Horne / Helen Gemignani / Nancy Miller / P.H. HFM / / Position Team Leader / external statistician / General / Regulatory Project Manager Chair / Executive / Chief / / Product HFM-217 / CERVARIX / HPV-048 / / ProgrammingLanguage ML / / Technology firewall / antibodies / /
SocialTag |